A Phase I/II Study of Pembrolizumab in Combination With Nab-Paclitaxel in Patients With Unresectable Stage III or Stage IV Non-Small Cell Lung Carcinoma
The purpose of this study is to determine the optimal dose of nab-paclitaxel to be safely
administered in combination with pembrolizumab in patients with advanced inoperable
non-small cell lung cancer. The study is also aimed at evaluating the efficacy of the
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society